ArticleApplied health economics and health policy2024

Cost-Utility Analysis of TNF-α Inhibitors, B Cell Inhibitors, and JAK Inhibitors Versus csDMARDs for Rheumatoid Arthritis Treatment.

Madhumitha Haridoss et al.PubMed ↗Publisher ↗

No numbers read from the abstract.